Log in to search using one of your social media accounts:


Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements

Medicare patients suffering from chronic peripheral nerve pain will have greater access to treatment starting January 1, 2018 VALENCIA, Calif., Dec. 7, 2017 -- (Healthcare Sales &Marketing Network) -- Bioness, Inc., the leading provider of cutting edg... Devices, Neurology, Reimbursement Bioness, StimRouter, Neuromodulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

More News: Brain | Chronic Pain | Marketing | Medicare | Neurology | Pain | Pharmaceuticals